Henri Guy
Impact in
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility
- Epidemiology top 5%
- Fungal Infections and Studies
- Pneumocystis jirovecii pneumonia detection and treatment
- Nail Diseases and Treatments
Papers in
-
- Antifungal resistance and susceptibility 3
-
- Multiple Myeloma Research and Treatments 3
- Acute Myeloid Leukemia Research 2
- Co-authors
- Olivier Casasnovas (7 shared papers)Denis Caillot (9 shared papers)Alain Bernard (1 shared paper)Gérard Couillault (1 shared paper)David W. Denning (1 shared paper)Lionel Mannone (1 shared paper)F Piard (1 shared paper)O. Vagner (1 shared paper)
- Journals
- British Journal of Haematology (3 papers)Journal of Antimicrobial Chemotherapy (2 papers)American Journal of Hematology (1 paper)Journal of Clinical Oncology (1 paper)Cancer (1 paper)
- Partner nations
- FranceUnited Kingdom
In The Last Decade
Henri Guy
11 papers receiving 780 citations
Peers
Comparison fields: 5 of 71
- Infectious Diseases 557
- Epidemiology 438
- Small Animals 91
- Hematology 87
- Oncology 193
Countries citing papers authored by Henri Guy
This map shows the geographic impact of Henri Guy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henri Guy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henri Guy more than expected).
Fields of papers citing papers by Henri Guy
This network shows the impact of papers produced by Henri Guy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henri Guy. The network helps show where Henri Guy may publish in the future.
Co-authors
The 25 scholars most cited alongside Henri Guy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 477 | |
| 2 | 1997 | 78 | |
| 3 | 1993 | 65 | |
| 4 | 1992 | 59 | |
| 5 | 1994 | 55 | |
| 6 | 1991 | 35 | |
| 7 | 1995 | 31 | |
| 8 | 1992 | 17 | |
| 9 | 1992 | 9 | |
| 10 | 1995 | 4 | |
| 11 | 1989 | 3 |
About Henri Guy
Henri Guy is a scholar working on Infectious Diseases, Hematology, Oncology, Genetics and Pathology and Forensic Medicine, having authored 11 papers that have together received 833 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (3 papers), Multiple Myeloma Research and Treatments (3 papers), Acute Myeloid Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Chemokine receptors and signaling (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Dermatological and COVID-19 studies (1 paper). The work is most often cited by research in Infectious Diseases (557 citations), Epidemiology (438 citations), Small Animals (91 citations), Hematology (87 citations) and Oncology (193 citations). Henri Guy has collaborated with scholars based in France and United Kingdom. Frequent co-authors include Olivier Casasnovas, Denis Caillot, Alain Bernard, Gérard Couillault, David W. Denning, Lionel Mannone, F Piard, O. Vagner, Éric Solary and P. Chavanet. Their work appears in journals such as British Journal of Haematology, Journal of Antimicrobial Chemotherapy, American Journal of Hematology, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.